251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster

We discuss the theatrical merits and actual implications of Moderna CEO Stéphane Bancel's appearance before a committee led by Sen. Bernie Sanders. We also talk about the latest news in the life sciences, including Regeneron Pharmaceuticals' latest data for its powerhouse drug Dupixent, an about-face for Sarepta Therapeutics, and how the FDA appears to view biomarkers in neurological diseases.

Episode metadata supplied by the publisher feed · Published Mar 23, 2023

Embed this episode

Attribution link and audio player

NOW PLAYING

251: Bancel v. Bernie, Sarepta's FDA runaround, & Regeneron's ever-growing blockbuster

0:00 34:22

1×

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

Share this episode

Similar Episodes

No similar episodes found.

Similar Podcasts

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The Readout Loud?

This episode is 34 minutes long.

When was this The Readout Loud episode published?

This episode was published on March 23, 2023.

Can I download this The Readout Loud episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.

URL copied to clipboard!